William Pridgen - Jul 7, 2021 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
Director
Signature
/s/ Greg Duncan, Attorney-in-Fact
Stock symbol
VIRI
Transactions as of
Jul 7, 2021
Transactions value $
$5,951
Form type
4
Date filed
7/9/2021, 01:36 PM
Previous filing
Jun 23, 2021
Next filing
Dec 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIRI Common Stock Purchase $5.95K +942 +0.13% $6.32* 711K Jul 7, 2021 Direct F1, F2
holding VIRI Common Stock 3.5K Jul 7, 2021 401 (k) Account F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021.
F2 Does not include 18,201 shares that were previously reported on the reporting person's Form 3 and prior Forms 4. Such shares were included in the person's holdings in error.
F3 The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.